MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - RANBAXY LABORATORIES

Ranbaxy Laboratories

BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 24, 17:00
390.30
-2.85 (-0.72%)
VOLUME 206,975
AVERAGE VOLUME
5-Day 236,723
10-Day 237,146
30-Day 132,049
VOLUME SHOCKER
5-Day 236,723
10-Day 237,146
30-Day 132,049
Prev. Close
393.15
Open Price
397.45
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
390.30 (5)
Today’s Low/High 386.00 401.00
52 Wk Low/High 370.50 578.30
LIVE
NSE
May 24, 17:00
389.70
-4.60 (-1.17%)
VOLUME 1,613,901
AVERAGE VOLUME
5-Day 1,752,293
10-Day 1,604,795
30-Day 957,408
VOLUME SHOCKER
5-Day 1,752,293
10-Day 1,604,795
30-Day 957,408
Prev. Close
394.30
Open Price
399.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
389.70 (302)
Today’s Low/High 385.40 401.00
52 Wk Low/High 370.80 578.40
Action in Ranbaxy Laboratories
MARKET CAP (Rs Cr)
16,513.63
*P/E
-
*BOOK VALUE (Rs)
45.40
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
27.54
*EPS (TTM)
-
*P/C
-
*PRICE/BOOK
8.60
DIV YIELD.(%)
-%
FACE VALUE (Rs)
5.00
DELIVERABLES (%)
30.52 new
DELIVERY AVERAGES
3-Day 31.54%
5-Day 35.83%
8-Day 33.76%
* Based on standalone numbers
Track Ranbaxy Labs on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL
Would you bet on Ranbaxy Labs today?
Test your strategy with virtual money on Moneybhai
F&O Quote
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 506.70 397.45  
High Price 532.00 401.00  
Low Price 501.70 386.00  
Last Price 526.45 390.30 -25.86
Volume 341,640 206,975 -39.42
Simple Moving Averages
Days BSE NSE
30 447.08 447.35
50 443.68 443.91
150 470.08 470.26
200 486.18 486.36

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Ranbaxy Labs

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Mar '13)
Quarterly
(Dec '12)
Yearly
Net Sales 1381.64 6303.54
Other Income 52.33 239.60
PBDIT 84.21 700.08
Net Profit 70.15 -162.34
Balance Sheet
(Dec '12)
(In Rs Cr)
Total Share Capital 211.46
Net Worth 1922.08
Total Debt 4763.61
Net Block 1993.53
Investments 3131.17
Net Current Assets 1401.38
Total Assets 6685.68
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 969.65 -3.67 1016.70 569.00 100,415.20
Dr Reddys Labs 2065.20 0.69 2150.90 1555.00 35,074.63
Lupin 769.80 2.79 810.80 519.00 34,459.10
Cipla 408.25 -1.63 435.00 305.00 32,779.26
GlaxoSmithKline 2267.65 -0.52 2522.00 2005.00 19,207.68
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 13Dec' 12Sep' 12Jun' 12
Promoter63.5263.5463.6463.66
FII10.5510.6510.579.66
DII10.0310.3910.6311.08
Others15.9015.4215.1615.60
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar
City
Mohali
State
Punjab
Pin Code
160071
Tel. No.
0172-6678666
Fax No.
0172-5013376
REGISTRARS
Name
Alankit Assignment Ltd.
Address
2E/8, Blazeflash House, R T A Division, 1st Floor Jhandewalan Extension,
City
New Delhi - 110055
State
Delhi
Tel. No.
011-51540060, 51540061, 51540062, 51540063
Fax No.
011-51540064
Internet
MANAGEMENT
Name
Designation
Tsutomu Une
Chairman
Arun Sawhney
Managing Director & CEO
Akihiro Watanabe
Director
Anthony H Wild
Director
Kazunori Hirokawa
Additional Director
Message Board & Community
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.